Table 1.
Patient demographic and clinical characteristics in groups of women undergoing one of three different cycle regimens for FTET
| Natural (n = 310) | Natural + hCG (n = 134) | HT (n = 204) | P value | |
|---|---|---|---|---|
| Age (years) | 34.2 ± 3.7 | 33.7 ± 3.3 | 33.7 ± 3.7 | NS |
| BMI (kg/m2) | 20.7 ± 2.8 | 20.5 ± 3.5 | 20.7 ± 2.4 | NS |
| Infertility duration (years) | 3.4 ± 2.1 | 3.9 ± 3.5 | 3.1 ± 2.9 | NS |
| Indications for treatment (%) | NS | |||
| Tubal factor/peritoneal | 133 (42.9) | 67(50) | 99(48.5) | |
| Male factor | 79 (25.4) | 35 (26.1) | 51(25) | |
| Ovulatory | 21(6.8) | 8(5.9) | 18(8.8) | |
| Unexplained | 77(24.8) | 24 (17.9) | 36(17.6) | |
| Basal FSH (mIU/ml) | 6.9 ± 2.4 | 6.7 ± 2.1 | 6.5 ± 2.6 | NS |
| Basal E2 (pg/ml) | 28.5 ± 18.6 | 26.4 ± 17.8 | 23.9 ± 17.7 | NS |
NS not statistically significant (P > 0.05)
Values are reported as means±standard deviations, or as numbers